Shire PLC sued Mylan Inc. on Thursday in New York over a planned generic version of the attention deficit hyperactivity disorder treatment Vyvanse, marking the company's latest effort to protect the market for its top selling product.
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Direct access to case information and documents.
All significant new filings across U.S. federal district courts, updated hourly on business days.
Full-text searches on all patent complaints in federal courts.